He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

The average weight loss among those ... weight after 68 weeks, compared to 3.1% for those taking a placebo. The study from the maker of Ozempic and Wegovy follows the first Phase 3 trial results ...

There is a new class of weight loss medications such as Ozempic and Wegovy, which are brand names ... thigh or upper arm once a week and is intended for long term use. Taking one of these drugs ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

Zepbound and Wegovy ... up to 6 weeks after initial visit to receive a prescription provides one-on-one health coaching and regular follow-ups with a professional combines weight loss medication ...

A version of this article first appeared in CNBC's Healthy Returns ... the active ingredient in the company's blockbuster weight loss drug Wegovy and diabetes treatment Ozempic.